Natco Pharma

Natco Pharma Ltd Half Yearly Results

NSEBSE

₹881.65

(2.15%)

Jun 10, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Mar-2025	Sept-2024	Mar-2024	Sept-2023	Mar-2023
Gross Sales	1,695.8	2,733.7	1,826.9	2,171.9	1,390.4
Excise Duty	0	0	0	0	0
Net Sales	1,695.8	2,733.7	1,826.9	2,171.9	1,390.4
Other Operating Income	0	0	0	0	0
Other Income	242.6	111.9	79	49.1	49.8
Total Income	1,938.4	2,845.6	1,905.9	2,221	1,440.2
Total Expenditure	1,108.9	1,124.6	1,061.5	1,185.9	945.4
PBIDT	829.5	1,721	844.4	1,035.1	494.8
Interest	14.6	9.3	10.8	8.4	6.5
PBDT	814.9	1,711.7	833.6	1,026.7	488.3
Depreciation	145.3	89.9	99.7	87.1	82.5
Minority Interest Before NP	0	0	0	0	0
Tax	139.9	297.7	142.5	174	76.5
Deferred Tax	-8.7	-20.9	-7.6	-23.7	-8.8
Reported Profit After Tax	538.4	1,345	599	789.3	338.1
Minority Interest After NP	-1.2	-0.8	0	0	0
Net Profit after Minority Interest	539.6	1,345.8	599	789.3	338.1
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	539.6	1,345.8	599	789.3	338.1
EPS (Unit Curr.)	30.15	75.14	33.46	43.88	18.53
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	225	0	0	0
Equity	35.8	35.8	35.8	35.8	36.5
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	48.91	62.95	46.22	47.65	35.58
PBDTM(%)	-	-	-	-	-
PATM(%)	31.74	49.2	32.78	36.34	24.31

No Record Found

Invest wise with Expert advice